This study aimed to evaluate quality of life (QoL) and psychological vulnerability (anxiety, stress and depression) of patients with multiple sclerosis (MS) who would undergo Hematopoietic Stem Cell Transplantation (HSCT). The sample consisted of 13 patients. The following instruments were used: MOS 36-Item Short-Form Health Survey (SF-36), Hospital Anxiety and Depression Scale (HAD) and Lipp's Stress Symptoms Inventory for Adults (ISSL). Data analysis was performed according to specific recommendations for each instrument. The obtained results showed that the physical and mental damage the illness (and/or transplantation) imposed is significantly related with the emergence of depression, anxiety and stress in participants.
Multiple sclerosis; hematopoietic stem cells transplantation; quality of life; anxiety; depression
